Wang Xiao-Ming, Zhang Yuan-Hui, Meng Chen-Chen, Fan Lu, Wei Lei, Li Yan-Yang, Liu Xue-Zheng, Lv Shi-Chao
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Front Public Health. 2024 Dec 18;12:1424613. doi: 10.3389/fpubh.2024.1424613. eCollection 2024.
As the population ages, the prevalence of age-related frailty increases sharply, which increases the risk of poor health status of older adults, such as disability, falls, hospitalization, and death. Across the globe, frailty is moving toward the forefront of health and medical research. Currently, frailty is believed to be preventable and reversible, so the early identification of frailty is critical. However, there are neither precise biomarkers of frailty nor definitive laboratory tests and corresponding clinical testing techniques and equipment in clinical practice. As a result, the clinical identification of frailty is mainly achieved through the widely used frailty scale, which is an objective, simple, time-saving, effective, economical, and feasible measurement tool. In this narrative review, we summarized and analyzed the various existing frailty scales from different perspectives of screening and evaluation, aiming to provide a reference for clinical researchers and practitioners to judge and manage frail older people accurately.
随着人口老龄化,与年龄相关的衰弱患病率急剧上升,这增加了老年人健康状况不佳的风险,如残疾、跌倒、住院和死亡。在全球范围内,衰弱正走向健康和医学研究的前沿。目前,人们认为衰弱是可预防和可逆的,因此早期识别衰弱至关重要。然而,在临床实践中,既没有精确的衰弱生物标志物,也没有明确的实验室检测方法以及相应的临床检测技术和设备。因此,衰弱的临床识别主要通过广泛使用的衰弱量表来实现,这是一种客观、简单、省时、有效、经济且可行的测量工具。在这篇叙述性综述中,我们从筛查和评估的不同角度对现有的各种衰弱量表进行了总结和分析,旨在为临床研究人员和从业者准确判断和管理衰弱老年人提供参考。